mice, and were accompanied by moderate increases in plasma aldosterone and urea concentrations. However, treatment with triamterene in sgk1 -/-mice (but not in sgk1 +/+ mice) led to severe, eventually lethal, body weight loss as well as increases in plasma aldosterone, urea and K + concentrations. Conclusions: SGK1 is required for diuretic tolerance to triamterene. The observations confirm the impaired kaliuretic potency of sgk1 -/-mice and point to a role of SGK1 in renal Na + reabsorption by mechanisms other than ENaC.
Introduction
Serum-and glucocorticoid-inducible kinase 1 (SGK1) was originally cloned as a glucocorticoid-inducible gene [1] and was subsequently found to be involved in the signal transduction pathway of the mineralocorticoid aldosterone [2] . SGK1 is expressed in the aldosterone-sensitive distal nephron [3] and stimulates the heterologously expressed epithelial sodium channel (ENaC) [4] [5] [6] . Moreover, in vitro experiments revealed the ability of SGK1 to stimulate a wide variety of further channels and transporters [7] [8] [9] [10] [11] [12] [13] [14] , including the renal outer medullary K 120 channel 1 [15] , Na + /H + exchanger NHE3 [16, 17] , Na + -K + -2Cl -cotransporter (NKCC2) [18] and Na + /K + -ATPase [19, 20] .
The physiological significance of SGK1 in the regulation of renal salt excretion became apparent from the comparison of gene-targeted mice lacking SGK1 ( sgk1 -/-) and their wild-type littermates ( sgk1 +/+ ). Renal Na + retention is moderately impaired in sgk1 -/-mice [21, 22] , which contrasts with the severely impaired phenotype of mice lacking functional ␣ -ENaC [23, 24] , ␤ -ENaC [25] , ␥ -ENaC [26] or the mineralocorticoid receptor [27] . In sgk1 -/-mice, the defective regulation of renal Na + excretion only becomes apparent after exposure to a salt-deficient diet, which unmasks the limited ability of the sgk1 -/-mice to decrease their urinary Na + output despite higher plasma aldosterone concentrations [21, 22] .
The salt-losing phenotype of the sgk1 -/-mice could not be explained on the basis of impaired ENaC regulation alone. During a low-salt diet, amiloride-sensitive Na + currents were even greater in sgk1 -/-than in sgk1 +/+ mice [21] , presumably a result of enhanced plasma aldosterone concentrations in sgk1 -/-mice. Western analysis in those mice revealed decreased expression of the Na + -Cl -cotransporter (NCC) in sgk1 -/-mice, which presumably contributed to renal salt loss in those mice. Beyond that, SGK1 may participate in the regulation of renal salt excretion by modifying further transport mechanisms, such as NHE3 or NKCC2 [10] .
The deranged regulation of renal tubular Na + transport in sgk1 -/-mice is expected to impact on the effects of diuretics. By inducing volume and Na + losses, diuretics cause counter-regulatory changes in sympathetic nerve activity, hormone secretion and the kidney itself, which involves up-regulation of the abundance of Na + channels both at the site of diuretic action as well as at distal sites [28, 29] . The latter can be attributed to the activation of the renin-angiotensin axis and secondary hyperaldosteronism [30, 31] , which is expected to involve the activation of SGK1. If SGK1 influences renal salt excretion exclusively through stimulation of ENaC, pharmacological inhibition of ENaC should dissipate the differences between sgk1 -/-and sgk1 +/+ mice. If, however, SGK1-dependent regulation of further Na + transport systems is critical for renal Na + retention, the salt-losing phenotype of sgk1 -/-mice would be compounded by the inhibition of ENaC.
The present study thus aimed to define the potency of the diuretics triamterene, furosemide, canrenoate and hydrochlorothiazide in sgk1 -/-and sgk1 +/+ mice.
Methods

Animal Experiments
Experiments were performed on SGK1 knockout mice (sgk1 -/-) and their wild-type littermates (sgk1 +/+ ) maintained on a 129S1/ SvImJ background with minor genetic contamination from C57Bl/6. The mice were bred as described elsewhere [22] . Mice were kept on a 12: 12 light-dark cycle and fed a standard diet (C1310, Altromin, Lage, Germany; measured Na + content 123 mol/g food, Cl
-100 mol/g food, K + 282 mol/g food) with tap water (measured Na + content 0.8 m M ) ad libitum. All animal experiments were conducted according to the guidelines of the American Physiological Society as well as laws governing the welfare of animals in Germany, and were approved by the local authorities.
Mice were studied for 2 days on tap water for the determination of the baseline (control) values and then subsequently for 8 days on diuretic treatment. Two to 3 series consisting of 6 sgk1 -/-and 6 sgk1 +/+ mice, respectively, were studied under each treatment. Series using different drugs were performed consecutively. Diuretics were supplied in the drinking water without any electrolyte supplementation. Furosemide (125 mg/l) was applied to block NKCC2 in the loop of Henle, hydrochlorothiazide was applied (400 mg/l, pH 4.5) to block NCC of the early distal tubule, triamterene (200 mg/l, pH 3) was applied to block the epithelial sodium channel (ENaC) of the late distal tubule, and canrenoate (800 mg/l) was applied to block the mineralocorticoid receptor. A control series delivering tap water at pH 3 was tolerated well without signs of reduced well-being or weight loss. The drugs were delivered in light-protected bottles.
Blood samples were drawn prior to and at the end of diuretic treatment by puncturing the right retro-orbital plexus under light anesthesia with diethyl ether.
Measurements
Plasma concentrations of Na + and K + were measured by flame photometry (AFM 5051, Eppendorf, Germany). Plasma urea was measured by an enzymatic method (Lehmann, Berlin, Germany). Plasma aldosterone was measured using a RIA kit (Demeditec, Kiel, Germany).
Quantitative RT-PCR
To quantify SGK1 transcript levels in the kidney, sgk1 +/+ mice were killed after 8 days of diuretic or control treatment, and the kidneys were removed and rapidly frozen in liquid nitrogen (n = 6-8 each). Automated disruption and homogenization of frozen tissue of whole kidneys was performed using the MagNa Lyser Instrument TM (Roche Diagnostics, Mannheim, Germany). Cleared cell lysate was transferred for further RNA purification (RNAeasy Mini Kit, Qiagen, Hilden, Germany). Subsequently, 1 g of total RNA was reverse transcribed to cDNA utilizing the reverse transcription system (Bioscience, USA) with oligo(dT) primers according to the manufacturer's protocol. To determine SGK1 transcript levels, quantitative real-time PCR was applied with the LightCycler System (Roche Diagnostics, Mannheim, Germany) using the primers 5 -TGTCTTGGGGCTGTCCTG-TATG-3 (forward) and 5 -GCTTCTGCT GCTTCCTTCAC-AC-3 (reverse) for murine SGK1, yielding a product of 406 bp. PCR reactions were performed in a final volume of 20 l containing 2 l cDNA, 2.4 l MgCl 2 (3 M ), 1 l primer mix (0.5 M of both primers), 2 l cDNA Master SYBR Green I mix (Roche Mo-lecular Biochemicals, Mannheim, Germany), and 12.6 l DEPCtreated water. The transcript levels of the housekeeping gene GAPDH were determined for each sample using a commercial primer kit (Search LC, Heidelberg, Germany). PCR reactions for GAPDH were performed in a final volume of 20 l containing 2 l cDNA, 2 l primer mix (Search LC), 2 l cDNA Master SYBR Green I mix (Roche Molecular Biochemicals) and 14 l DEPCtreated water. The target DNA was amplified during 35 cycles of 95 ° C for 10 s, 68 ° C for 10 s and 72 ° C for 16 s; each with a temperature transition rate of 20 ° C/s, a secondary target temperature of 58 ° C and a step size of 0.5 ° C. A melting curve analysis was performed at 95 ° C for 0 s, 58 ° C for 10 s, and 95 ° C for 0 s to determine the melting temperatures of primer dimers and the specific PCR products. A melting curve analysis confirmed the amplified products. Finally, results were calculated as a ratio of the target versus the housekeeping gene GAPDH transcripts.
Immunof luorescence
For the analysis of SGK1 protein expression in the kidney, sgk1 +/+ mice were killed after 8 days of diuretic or control treatment, and the kidneys were rapidly frozen in liquid nitrogen (n = 2 sgk1 +/+ mice each). Frozen sections of whole kidneys without microdissection (3 m) were fixed in acetone (10 min at -20 ° C), air dried and stored in a Tris buffer for 5 min. Then blocking was performed with normal goat serum (blotto, 1: 5, 45 min). Afterwards, the primary antibody (rabbit anti-SGK1, 1: 50) was applied (1 h, 37 ° C) and the sections were washed in Tris buffer (3 ! 5 min). Polyclonal monospecific antibodies against the SGK1 protein were raised by a commercial antibody service (Dr. Pineda, Berlin, Germany) as described elsewhere [32] . Previous studies had shown that the target detected by this antibody colocalized with 11 ␤ -steroid dehydrogenase type 2 indicating the aldosterone-sensitive distal nephron [33] . Afterwards the secondary antibody (goat anti-rabbit, Alexa 488, 1: 200) was applied for 30 min. DAPI was used to stain nuclei (1: 1,000 in distilled water for 5 min), followed by rinsing in Tris buffer (3 ! 5 min). Finally, sections were covered with Mowiol and analyzed.
Statistics
Data are provided as arithmetic means 8 SEM; n represents the number of independent experiments. All data were tested for significance with a parametric or non-parametric unpaired Student's t test or Mann-Whitney test where applicable, using GraphPad InStat (GraphPad Software, San Diego, Calif., USA). p ! 0.05 was considered statistically significant.
Results
As analyzed by immunofluorescence, the treatment of wild-type animals with each of the diuretic drugs significantly increased SGK1 protein expression ( fig. 1 a) . Diuretic treatment led to the recruitment of additional renal tubules expressing appreciable levels of SGK1, i.e. the portion of the nephron regulated by SGK1 increased following diuretic induced fluid loss. According to quantitative RT-PCR, treatment was followed by a significant increase of the SGK1 transcript levels to similar values following an 8-day treatment with triamterene, furosemide, canrenoate and hydrochlorothiazide ( fig. 1 b) ) , triamterene intake was slightly reduced in sgk1 -/-mice ( fig. 2 a) . Under control conditions, food and fluid intake was similar in sgk1 -/ -and sgk1 +/+ mice ( fig. 2 b, c) . Food intake remained constant under treatment with triamterene and canrenoate ( fig. 2 b) . It increased slightly following treatment with furosemide and hydrochlorothiazide, reaching statistical significance in sgk1 +/+ mice. Under treatment with furosemide, fluid intake increased in both genotypes ( fig. 2 c) . Under treatment with triamterene, fluid intake was slightly, but significantly, lower in sgk1 -/-mice compared to sgk1 +/+ mice. Under treatment with canrenoate or hydrochlorothiazide, fluid intake was not altered significantly in either genotype. It is possible that the effects of thirst and the taste of the drugcontaining drinking water were partially counteractive.
Body weight was measured to assess the volume loss during diuretic treatment. As shown in figure 2 d, body weight loss under diuretic treatment was moderate ( ! 1.5 g) in sgk1
+/+ mice, irrespective of the diuretic drug used. The weight loss of sgk1 -/-mice was similarly low following diuretic treatment with furosemide, canrenoate and hydrochlorothiazide. In contrast, triamterene caused massive body weight loss in sgk1 -/-mice reaching -4.2 8 0.8 g after 8 days. During the treatment, 5 of 12 sgk1 -/-mice died, pointing to a severe disorder of electrolyte balance.
At control conditions, plasma sodium and potassium concentrations were similar in both genotypes and remained largely constant in both genotypes during treatment with furosemide, hydrochlorothiazide and canrenoate. In contrast, triamterene led to marked hyperkalemia in sgk1 -/ -mice, but not in sgk1 +/+ mice ( fig. 3 ). The alterations of body weight and plasma K + concentration reflect alterations in renal fluid and electrolyte loss, as -with the exception of furosemide treatmentfluid and food intake were only slightly modified by diuretic treatment. Even in the absence of diuretic treatment, daily fluid intake and urinary output may approach 5-15% of body weight in mice. Thus, even a moderate imbalance between intake and urinary output of fluid and electrolytes is followed by marked alterations in body weight and plasma electrolyte concentrations. Prior to diuretic treatment, plasma aldosterone concentrations were significantly higher in sgk1 -/ -than in sgk1 +/+ mice. In sgk1 +/+ mice, treatment with furosemide, hydrochlorothiazide and canrenoate tended to increase plasma aldosterone concentrations, an effect which did not reach statistical significance. In sgk1 -/ -mice, diuretic treatment similarly increased plasma aldosterone concentrations. This effect reached statistical significance during treatment with furosemide and hydrochlorothiazide, but not during treatment with canrenoate ( fig. 4 a) . Under triamterene treatment, plasma aldosterone concentrations increased in both sgk1 +/+ and sgk1 -/ -mice, an effect significantly more pronounced in sgk1 -/ -mice. Under control conditions, plasma urea concentrations tended to be higher in sgk1 -/ -and sgk1 +/+ mice. This difference, however, did not reach statistical significance ( fig. 4 b) . During diuretic treatment with furosemide, hydrochlorothiazide and canrenoate, plasma urea con- , open bars, n = 9-12). # Significant difference to the control value; * significant difference between sgk1 -/-and sgk1 +/+ mice.
Discussion
The present study shows that diuretic treatment with triamterene induces severe salt-wasting, hyperkalemia and death in gene-targeted mice lacking functional SGK1 ( sgk1 -/ -), indicating that SGK1 is critically required for the maintenance of electrolyte balance during pharmacological inhibition of ENaC. In contrast, diuretic treatment with furosemide, hydrochlorothiazide or canrenoate was tolerated similarly well in sgk1 -/ -mice as in their wild-type littermates (sgk1 +/+ ) . These results are surprising in view of the well-known role of SGK1 in the regulation of ENaC [4] [5] [6] . If the renal tubular effect of SGK1 was restricted to upregulation of ENaC, pharmacological inhibition of ENaC would be expected to dissipate the differences between sgk1 -/ -and sgk1 +/+ mice. The opposite has been observed, indicating that sgk1 -/ -mice are critically dependent on ENaC activity for the maintenance of their electrolyte balance. The present experiments cannot rule out the possibility that triamterene and the lack of SGK1 exert additive effects on ENaC activity leading to a more complete inhibition of ENaC activity than either triamterene treatment or a lack of SGK1 alone. Moreover, the present data do not rule out the possibility that triamterene decreases body weight and compromises survival of sgk1 -/ -mice by mechanisms other than inhibiting ENaC. Nevertheless, the present observations may point to a critical role for SGK1-dependent renal Na + reabsorption other than ENaC. The latter possibility is supported by a recent study, which provided convincing evidence for SGK1-dependent stimulation of renal Na + reabsorption involving transport systems other than ENaC [21] . In this study, amiloride-sensitive Na + currents in isolated collecting ducts were not reduced in sgk1 -/ -mice [21] . Under a lowsalt diet, amiloride-sensitive Na + currents were found to be even higher in sgk1 -/ -than in sgk1 +/+ mice [21] . The renal Na + loss may have been partially due to decreased expression of the NCC rather than to impaired ENaC activity [21] . Along those lines, amiloride-sensitive Na + currents across the colonic epithelium were significantly higher in sgk1 -/ -than in sgk1 +/+ mice [34] . Regulation of ENaC by mineralocorticoids is not critically dependent on SGK1, but can be circumvented by enhanced expression of the channel protein. Aldosterone rescues the mice via ENaC activation also, especially in the absence of SGK1. SGK1 is critically important for the stimulation of ENaC by insulin, and renal Na + excretion is lowered following insulin infusion in sgk1 +/+ mice but not in sgk1 -/-mice [35, 36] .
According to a previous study [33] , the deleterious effects of triamterene in sgk1 -/ -mice were attenuated during concomitant treatment with the peroxisome proliferator-activated receptor-␥ (PPAR-␥ ) agonist pioglitazone. In that study, mean body weight loss was only -1.6 g after 8 days without any deaths in sgk1 -/ -mice. This finding may result from the volume retaining effects of pioglitazone, which are only partially dependent on SGK1 [33] . PPAR-␥ activation has been said to involve direct genomic upregulation of ENaC [37] , which, however, would again be inhibited by triamterene. Pioglitazone may have an influence on renal Na + excretion through its genomic regulation of further renal transport systems.
The death of sgk1 -/ -mice following triamterene treatment may have been due to volume depletion leading to acute prerenal failure complicated by severe hyperkalemia. The excessive hyperkalemia may be exacerbated by the critical role of SGK1 in the regulation of K + excretion [38] . The ability of sgk1 -/-mice to excrete an acute K + load is impaired despite increased basal plasma aldosterone concentrations [38] . Moreover, sgk1 -/-mice require marked increases of plasma K + and aldosterone concentrations to excrete a chronic K + load [38] . The impaired ability of sgk1 -/-mice to eliminate a K + load may be related to its role in (1) the regulation of the renal outer medullary K + channel or some other renal epithelial K + channel, (2) decreased electrical driving force secondary to decreased ENaC activity and/or (3) Na + /K + -ATPase activity. Besides its role in the regulation of renal K + elimination, SGK1 is critically important for the stimulation of cellular K + uptake by insulin [39] . Diuretic tolerance occurs during long-term treatment with any diuretic. This leads to a new steady state at a reduced extracellular volume, accounted for by reduced body weight. Various counter regulatory mechanisms are involved in mediating diuretic tolerance such as the activation of the renin-angiotension-system and secondary hyperaldosteronism, increased sympathetic activity and the release of vasopressin [30, 31] . At the level of the renal tubules, the abundance of Na + channels, both at the site of diuretic action and at distal sites, are increased [28] . Western blot studies have shown an increase in ENaC membrane abundance during treatment with furosemide, thiazide or amiloride in rats [29] which might involve activation of SGK1. The present data indicate that diuretic treatment is indeed followed by upregulation of SGK1 transcription involving a larger number of tubules. However, the lack of SGK1 was only limiting during triamterene treatment, not during treatment with furose-mide or thiazide, which points to an intact ENaC upregulation without SGK1.
Plasma aldosterone levels are invariably increased in sgk1 -/ -mice even under a controlled diet [21, 22] . However, blockade of the mineralocorticoid receptor by canrenoate did not lead to a stronger natriuretic effect in sgk1 -/ -mice. Thus, mineralocorticoid receptors may not be critically important for the fluid retention in sgk1 -/ -mice. It should be kept in mind that the function of ENaC is not exclusively dependent on functional mineralocorticoid receptors, as residual ENaC activity was observed in gene-targeted mice lacking functional mineralocorticoid receptor s [27] .
The present observations strongly suggest that SGK1 is not only involved in the regulation of ENaC, but also influences further renal tubular Na + transport systems.
Candidate systems include NHE3 [16, 17] , NKCC2 [18] , NCC [21] and Na + /K + -ATPase [19, 20] . The use of diuretics cannot, however, lead to an unequivocal definition of the transport systems, as the inhibition of any system will be paralleled by upregulation of other systems [28] .
In conclusion, SGK1 is critically required for diuretic tolerance to triamterene. Accordingly, mice deficient in SGK1 seem to be critically dependent on residual ENaC activity.
